Can CAC absence identify patients with chest pain who can safely avoid additional downstream testing?
USA: The findings from a new study, published in JACC: Cardiovascular Imaging, support the role of a CAC score of 0 as a gatekeeper for more advanced imaging among patients with either stable or acute chest pain (CP).
The study found that among more than 92,000 patients presenting with chest pain, CAC absence was associated with a very low prevalence of obstructive CAD, a low annualized risk of major adverse cardiac events, and a low prevalence of nonobstructive CAD.
There is not much consensus on whether the absence of coronary artery calcium (CAC) can help to identify chest pain patients who can safely avoid additional downstream testing. Considering this, Ali M. Agha, Baylor College of Medicine, Houston, Texas, USA, and colleagues aimed to investigate the use of CAC assessment for ruling out obstructive coronary artery disease (CAD) in patients with stable and acute CP, at low-to-intermediate risk of obstructive CAD undergoing coronary computed tomography angiography (CTA) by conducting a systematic review and meta-analysis.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.